Mastodon

Pini-Oil (Drops) Instructions for Use

Marketing Authorization Holder

Vifitech, CJSC (Russia)

ATC Code

R01AX30 (Other nasal preparations for topical use in combination)

Dosage Form

Bottle OTC Icon Pini-Oil Nasal drops: fl. 10 ml

Dosage Form, Packaging, and Composition

Nasal drops in the form of a transparent liquid from blue to blue with a greenish tint, with a characteristic odor.

10 g
Pine oil 0.3752 g
α-Tocopherol acetate 0.17 g
Peppermint oil 0.1 g
Eucalyptus oil 0.05 g
Thymol 0.0032 g
Guaiazulene 0.002 g

Excipients: Labrafil M-1944-CS – 1 g, butylhydroxyanisole – 0.0012 g, sunflower oil – 8.2984 g.

10 ml – bottles (1) – cardboard packs.

Clinical-Pharmacological Group

A drug with antimicrobial and anti-inflammatory action for topical use in ENT practice

Pharmacotherapeutic Group

Decongestant of plant origin

Pharmacological Action

It has anti-inflammatory and antiseptic action.

Indications

  • Acute rhinitis.
  • Chronic atrophic rhinitis.
  • Acute and chronic inflammatory diseases of the nasal and nasopharyngeal mucous membranes, accompanied by dryness of the nasal mucous membranes.
  • Conditions after surgical intervention in the nasal cavity – as prescribed by a physician (in inpatient and outpatient settings).

ICD codes

ICD-10 code Indication
J00 Acute nasopharyngitis (common cold)
J31.0 Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis)
Z98.8 Other specified postprocedural states
ICD-11 code Indication
CA00 Acute nasopharyngitis
CA09.0 Chronic rhinitis
QB6Z Surgical or postprocedural conditions, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer topically into the nasal passages. The specific dosage regimen is individualized and depends on the stage of the disease and the patient’s age.

The typical duration of a treatment course is 5-7 days. As an alternative to direct instillation, the drug can be administered via inhalation.

Adverse Reactions

Local reactions: itching, burning sensation, hyperemia and swelling of the nasal mucosa, nasal discomfort.

Other: hypersensitivity reactions.

Drug Interactions

No specific drug interactions have been reported to date. Avoid concurrent use with other topical nasal preparations to prevent potential local irritation or incompatibility.

Contraindications

  • Hypersensitivity to any component of the drug.
  • Allergic rhinitis.
  • Children under 2 years of age.

Overdose

Symptoms of overdose may include intensified adverse reactions, such as severe local irritation of the nasal mucosa. Treatment is symptomatic and supportive. Discontinue use immediately.

Use in Pregnancy and Lactation

Use during pregnancy and lactation (breastfeeding) is possible as indicated.

Pediatric Use

Contraindicated for use in children under 2 years of age.

Special Precautions

It is necessary to avoid getting the drug on the mucous membrane of the eyes.

Frequent and/or prolonged use may lead to dryness of the nasal mucosa.

For conditions after surgical intervention in the nasal cavity, use only as prescribed by a physician.

Storage Conditions

Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Table of Contents

→ TABLE OF CONTENTS